The chevrolet camaro was discontinued. And then they brought it back. We can trade analogies all day long. It doesn't change the fact that you are the only person who thinks there is an issue with the trial.

And no one else cares. I still believe it may work in gvhd based on the data from animal trials and other ccr5 studies.

But it's a small target. One we may not get to for a while anyway.

But if whatever narrative you are trying to push about it being a failure is true, I'll be dissapointed that CYDY only has 49 indications.

In other words the impact to the stock price will be tantamount to a rounding error.